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Abstract
Signaling crosstalk between complement and Toll-like receptors (TLRs) normally serves to coordinate
host immunity. However, the periodontal bacterium Porphyromonas gingivalis expresses C5 convertaselike enzymatic activity and adeptly exploits complement-TLR crosstalk to subvert host defenses and
escape elimination. Intriguingly, this defective immune surveillance leads to the remodeling of the
periodontal microbiota to a dysbiotic state that causes inflammatory periodontitis. Understanding the
mechanisms by which P. gingivalis modulates complement function to cause dysbiosis offers new
targets for complement therapeutics.
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Signaling crosstalk between complement and Toll-like receptors (TLRs) normally serves to
coordinate host immunity. However, the periodontal bacterium Porphyromonas gingivalis
expresses C5 convertase-like enzymatic activity and adeptly exploits complement-TLR crosstalk
to subvert host defenses and escape elimination. Intriguingly, this defective immune surveillance
leads to the remodeling of the periodontal microbiota to a dysbiotic state that causes inflammatory
periodontitis. Understanding the mechanisms by which P. gingivalis modulates complement
function to cause dysbiosis offers new targets for complement therapeutics.

Introduction
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Microbial pathogens which successfully disarm, suppress, or delay host defenses target
preferentially innate immunity (Finlay and McFadden, 2006) and particularly key systems
such as complement and the Toll-like receptor (TLR) family of pattern-recognition receptors
(Hajishengallis and Lambris, 2011). Collectively, complement and TLRs sense pathogens
through “pattern recognition” and “missing-self recognition” strategies and trigger the
activation of antimicrobial and inflammatory responses, as well as the initiation of the
adaptive immune response (Kawai and Akira, 2010; Ricklin et al., 2010). Until relatively
recently, both systems were primarily investigated as separate entities. However, a
substantial body of literature has demonstrated extensive crosstalk between complement and
TLR signaling pathways (Hajishengallis and Lambris, 2010; Hawlisch et al., 2005; la Sala et
al., 2005; Zhang et al., 2007). Both synergistic and antagonistic interactions between
complement and TLRs have been described which apparently serve to invigorate the host
response or regulate it to prevent unwarranted inflammatory responses (Ricklin, et al.,
2010). Therefore, pathogens targeting complement and/or TLRs have the opportunity to
infiltrate an extensive network of signaling pathways in ways that could impair innate host
defense and, moreover, deregulate the induction of adaptive immunity or divert it in ways
that favor their survival.
In this review we focus on Porphyromonas gingivalis, a gram-negative oral anaerobic
bacterium recently shown to manipulate complement-TLR crosstalk to enhance its survival
and virulence (Hajishengallis et al., 2007; Hajishengallis et al., 2011; Liang et al., 2011;

© 2012 Elsevier GmbH. All rights reserved
Correspondence: geoh@upenn.edu and lambris@upenn.edu.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
*

Hajishengallis and Lambris

Page 2

NIH-PA Author Manuscript

Wang et al., 2007; Wang et al., 2010) (Figure 1). Importantly, these subversion mechanisms
are highly relevant in the context of the collective virulence of the microbial community in
which P. gingivalis resides. Specifically, P. gingivalis can act as a “keystone pathogen”
which remodels the commensal microbiota into a dysbiotic partner that disrupts the
homeostatic balance with the host tissue leading to destructive inflammation in periodontitis
(Hajishengallis, et al., 2011) (Figure 2).
Periodontitis is a biofilm-driven chronic inflammatory disease that affects the toothsupporting tissues (periodontium) leading, in some cases, to tooth loss (Pihlstrom et al.,
2005). This oral disease affects the majority of adults, whereas an estimated 10–15%
develops severe periodontitis, which increases the patients' risk for atherosclerosis,
aspiration pneumonia, diabetes, adverse pregnancy outcomes, and perhaps rheumatoid
arthritis (Genco and Van Dyke, 2010; Lalla and Papapanou, 2011; Lundberg et al., 2010;
Pihlstrom, et al., 2005; Tonetti et al., 2007; Xiong et al., 2006).
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Periodontitis is characterized by dramatic changes in the numbers and composition of the
periodontal bacterial community relative to health (Moore et al., 1982; Socransky, 1977;
Socransky and Haffajee, 2005). It has recently been proposed that periodontitis
fundamentally represents disruption of host-microbial homeostasis caused by dysbiosis of
the periodontal microbiota (Darveau, 2010; Hajishengallis, et al., 2011). According to this
notion, changes in the relative abundance of individual components of the microbiota
compared to their abundancies in health can lead to alterations in the host-microbial
crosstalk sufficient to initiate inflammatory disease.
Although P. gingivalis is a quantitatively minor component of periodontal pathogenic
biofilms, its presence has been associated with progressive bone loss in periodontitis patients
(Chaves et al., 2000; Doungudomdacha et al., 2000; Kumar et al., 2006; Moore, et al., 1982;
Moore et al., 1991; Socransky et al., 1998). However, the fundamental mechanism by which
P. gingivalis may contribute to a polymicrobial disease such as periodontitis has remained
elusive until recently. As alluded to above, useful insights have been provided by a study in
the mouse model of periodontitis which demonstrated that P. gingivalis can act as a
kesystone pathogen which reshapes an otherwise harmless periodontal microbiota into a
disease-provoking microbiota (Hajishengallis, et al., 2011).
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The capacity of P. gingivalis to act as a keystone member of the periodontal microbiota is
dependent, in great part, upon its ability to exploit complement and TLRs (Hajishengallis, et
al., 2011) (Table 1). Subversion of complement and TLRs might also account for the ability
of P. gingivalis to relocate to systemic tissues and contribute to disease. In this regard, P.
gingivalis is a common isolate from aspiration pneumonia and lung abscesses (Finegold,
1991; Okuda et al., 2005) and has been detected in a viable state in atherosclerotic plaques
(Kozarov et al., 2005). Below we summarize and discuss recently established mechanisms
whereby P. gingivalis can manipulate complement to sabotage its functions and its
productive interactions with TLRs. In this way, the host response is diverted to favor the
pathogen and its microbial community leading to dysbiosis and destructive inflammation in
the periodontal tissue.

Complement inhibition by P. gingivalis
The interactions of P. gingivalis with complement are complex and include both inhibitory
and stimulatory effects (Krauss et al., 2010) (Table 1). This is not surprising given that
complement mediates diverse functions (Ricklin, et al., 2010), some of which could involve
effective antimicrobial action (targets of inactivation), while certain complement-dependent
inflammatory pathways could benefit the periodontal bacteria (targets of activation). P.
gingivalis can suppress complement activation, regardless of the initiation pathway involved
Immunobiology. Author manuscript; available in PMC 2013 November 01.
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(classical, lectin, or alternative) through gingipain-dependent degradation of C3 (Popadiak et
al., 2007). All three gingipain enzymes can cause complement inactivation, although the
Arg-specific enzymes (HRgpA and RgpB) are more potent than the Lys-specific gingipain
(Kgp) (Popadiak, et al., 2007). As a consequence of complement inhibition, the deposition
of opsonins or the membrane attack complex on the surface of P. gingivalis is suppressed,
whereas ablation of its gingipain activity by chemical or genetic means reverses these effects
(Potempa and Pike, 2009). For increased safety against complement, this bacterium seems to
hijack physiological inhibitors of the complement cascade. Indeed, P. gingivalis uses its
HRgpA to capture the circulating C4b-binding protein on the bacterial cell surface, and in
this way to negatively regulate the classical pathway C3 convertase (Potempa et al., 2008).
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It should be noted that other periodontal bacteria associated with periodontitis, such as
Prevotella intermedia, Tannerella forsythia, and Treponema denticola, also possess
mechanisms for escaping complement. Interpain A (InpA), a streptopain-like cysteine
protease secreted by some Prevotella intermedia strains, degrades C3 and contributes to
resistance against the antibacterial activity of complement (Potempa et al., 2009). Karilysin,
a metalloproteinase expessed by T. forsythia confers resistance to killing by human
complement by acting at different stages of complement activation: Specifically, karilysin
inhibits the classical and lectin pathways by degrading MBL, ficolin-2, ficolin-3, and C4,
whereas it blocks the terminal pathway by degrading C5 (Jusko et al., 2012). Importantly,
both InpA and karilysin synergize with gingipains in these functions suggesting that P.
gingivalis, P. intermedia, and T. forsythia together can better promote the survival in the
dental biofilm of bystander bacterial species, which could otherwise be readily eliminated by
the bactericidal activity of complement. T. denticola expresses a 11.4-kDa cell surface
lipoprotein which can bind factor H (McDowell et al., 2009). This function suggests that T.
denticola may escape complement-dependent killing by means of surface-bound,
biologically active factor H. Interestingly, however, after full-length factor H becomes
associated with T. denticola, the bacterium uses its serine protease dentilisin to cleave factor
H and generate a 50-kDa factor H fragment that remains attached to the bacterial surface
(McDowell, et al., 2009). An interesting question is whether the attached fragment retains
useful complement inhibitory activity to protect T. denticola against complement.
Alternatively, through this mechanism, dentilisin may in fact inactivate factor H and
deregulate complement, thereby promoting local inflammation which could also be
beneficial for periodontal bacteria (see next section).
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Intriguingly, the HRgpA and RgpB gingipains of P. gingivalis display C5 convertase-like
activity and generate biologically active C5a, whereas C5b is destroyed (Wingrove et al.,
1992). In heat-inactivated human serum, P. gingivalis can rapidly generate >30 nM of C5a
(Wang, et al., 2010). This activity seems counterproductive for the adaptive fitness of this
pathogen, since C5a is probably the most potent effector of the complement cascade and
generally promotes host defense, e.g., through chemotactic recruitment and activation of
leukocytes (Guo and Ward, 2005; Hopken et al., 1996). Strikingly, however, P. gingivalis
exploits C5a to manipulate TLR signaling (below).

Hijacking of C5aR-TLR2 crosstalk
The TLR system senses P. gingivalis primarily through TLR2, as shown by in vitro and in
vivo observations, which additionally have excluded a significant role for TLR4 (Burns et
al., 2006; Hajishengallis et al., 2006). The lack of significant TLR4 involvement in the host
response to P. gingivalis is counterintuitive given that this is a gram-negative bacterium that
expresses a lipopolysaccharide. However, P. gingivalis utilizes specific lipid A 1- and 4phosphatases and a deacylase which in concert generate a tetra-acylated and
dephosphorylated lipid A structure that is biologically inert (Coats et al., 2009). Moreover,
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high concentrations of hemin (as can be found in inflamed periodontal sites) suppress the
lipid A 1-phosphatase activity and lead to the generation of a mono-phosphorylated lipid A,
which acts as a TLR4 antagonist (Coats et al., 2005; Coats, et al., 2009) (Table 1). These
unique LPS features allow P. gingivalis to evade or antagonize TLR4 activation at the
receptor level. Moreover, this pathogen has evolved sophisticated complement-dependent
strategies to selectively intercept only a subset of TLR2 signaling events (Kagan, 2010;
Wang, et al., 2010). In this way, P. gingivalis can filter out pathways that could result in its
elimination, whereas it can selectively maintain or enhance host responses that favor its
survival.
Specifically, P. gingivalis instigates a C5aR-TLR2 subversive crosstalk that undermines the
killing function of macrophages. Indeed, P. gingivalis-generated C5a locally activates C5aR
and stimulates G!i-dependent intracellular Ca2+ signaling which synergistically enhances
an otherwise weak cAMP response by P. gingivalis-induced TLR2 activation alone. In this
crosstalk pathway, which additionally involves the participation of the CXC chemokine
receptor-4, elevated and sustained production of cAMP leads to the activation of the cAMPdependent protein kinase A which inactivates the glycogen synthase kinase-3" and impairs
nitric oxide-dependent killing of P. gingivalis (Hajishengallis et al., 2008; Wang, et al.,
2010).
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The P. gingivalis-induced C5aR-TLR2 crosstalk also regulates cytokine production in favor
of the pathogen (Liang, et al., 2011). Specifically, P. gingivalis proactively and selectively
inhibits TLR2-induced IL-12p70, whereas the same C5aR-TLR2 crosstalk upregulates
inflammatory and bone-resorptive cytokines (IL-1", IL-6, and TNF). In vivo, the ability of
P. gingivalis to manipulate TLR2 activation via the C5a-C5aR axis allows it to escape
IL-12p70-dependent immune clearance and to cause inflammatory bone loss in a murine
model of experimental periodontitis (Liang, et al., 2011). Therefore, by targeting C5aR, P.
gingivalis not only can promote its survival but also cause destructive inflammation.
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Because the C5aR-TLR2 crosstalk inhibits only a subset of TLR2 signaling events, C5aR
was characterized as a “TLR modulatory receptor” as opposed to “TLR inhibitory
receptors”, such as IL-10 receptor or TGF-" receptor, which block most, if not all,
inflammatory responses (Kagan, 2010). In fact, it would not be in the “best interest” of P.
gingivalis to induce a generalized immunosuppression, since such action would spare the
bacterium from leukocytes but, on the other hand, would probably starve it to elimination. In
this regard, P. gingivalis is a proteolytic and asaccharolytic organism the survival and
growth of which depend crucially on inflammatory tissue break down products (degraded
proteins) and gingival inflammatory fluid-derived hemin, a source of essential iron (Krauss,
et al., 2010). Therefore, inflammation is exploited by P. gingivalis as a means for survival,
although in a chronic setting this causes collateral damage to the periodontium.

Exploitation of the TLR2-CR3 inside-out signaling pathway
P. gingivalis appears to use a number of distinct but reinforcing mechanisms to escape
leukocyte killing. Thus, in addition to exploiting the C5aR-TLR2 crosstalk, it can also take
advantage of the TLR2 inside-out signaling pathway for complement receptor 3 (CR3)
transactivation. CR3 is a "2 integrin (CD11b–CD18) the binding activity of which is tightly
regulated: In resting cells, CR3 displays a low-affinity conformation, whereas a rapid and
transient shift to a high-affinity state can be triggered through inside-out signaling by
chemokine or anaphylatoxin receptors (Abram and Lowell, 2009). More recently, TLRs
were also shown to mediate inside-out signaling for CR3 activation (Han et al., 2010;
Harokopakis and Hajishengallis, 2005; Sendide et al., 2005). Tight regulation of the CR3
binding activity is important since this is a functionally versatile molecule involved in the
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phagocytosis of apoptotic cells, leukocyte trafficking, and regulation of cytokine production
(Ricklin, et al., 2010).
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However, CR3 activation may come under the control of P. gingivalis: The pathogen
induces TLR2-mediated transactivation of CR3 through an inside-out pathway that involves
Rac1, PI3K and cytohesin-1 (Harokopakis and Hajishengallis, 2005; Harokopakis et al.,
2006). This mechanism allows P. gingivalis to bind activated CR3 for a relatively safe
“outside-in” entry into macrophages. Indeed, CR3-deficient macrophages are superior to
wild-type macrophages in the intracellular killing of this oral pathogen (Hajishengallis et al.,
2006; Wang, et al., 2007). Moreover, pharmacological inhibition of CR3 greatly facilitates
the intracellular killing of P. gingivalis (Hajishengallis, et al., 2007). Antagonistic blockade
of CR3 also suppresses P. gingivalis-induced periodontal bone loss in the mouse
periodontitis model (Hajishengallis, et al., 2007).
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Although CR3 is a phagocytic receptor, it is not linked to strong microbicidal mechanisms
such as those activated by Fc#R-mediated phagocytosis (Caron and Hall, 1998; Lowell,
2006). This is possibly because CR3 is heavily committed with the phagocytosis of iC3bcoated apoptotic cells, which are not normally recognized as danger (Kim et al., 2004;
Mevorach et al., 1998). Furthermore, at least under certain conditions, CR3-derived
phagosomes do not fuse with lysosomes (Gatfield and Pieters, 2000). These observations
may explain why CR3 is a target of exploitation by P. gingivalis. Moreover, CR3 binding by
the fimbriae of P. gingivalis inhibits IL-12p70 production by macrophages (Hajishengallis,
et al., 2007) (Figure 1). Not surprisingly, therefore, the TLR2-CR3 crosstalk pathway is
exploited by several pathogens in addition to P. gingivalis (Harokopakis and Hajishengallis,
2005; Oliva et al., 2009; Sendide, et al., 2005).
In the context of the periodontitis-atherosclerosis connection (Seymour et al., 2007) and the
observation of viable P. gingivalis in atherosclerotic plaques (Kozarov, et al., 2005), it is
intriguing to hypothesize that the intracellular persistence of P. gingivalis in macrophages
(Huang et al., 2009; Wang, et al., 2007) might allow this organism to exploit these cells as
“Trojan horses” to relocate to systemic tissues and subsequently infect permissive cells (e.g.,
endothelial cells). Although this hypothesis remains to be tested, the capacity of P.
gingivalis for cell exit and infection of new host cells has already been demonstrated (Li et
al., 2008; Yilmaz, 2008).

P. gingivalis as an orchestrator of complement-dependent dysbiotic
inflammation
NIH-PA Author Manuscript

As pointed out above, there are stark differences in the composition of the periodontal
microbiota in health and disease (Darveau, 2010; Moore, et al., 1982; Socransky, 1977). The
assumption that these differences signified bacterial specificity in the etiology of
periodontitis led to significant progress, including the identification of a number of bacterial
species as putative periodontal pathogens. In addition to P. gingivalis, Treponema denticola
and Tannerella forsythia were also shown to be strongly associated with periodontitis. These
three species together comprise the so-called “red complex” and are frequently isolated
together from diseased sites (Holt and Ebersole, 2005; Socransky, et al., 1998). Over the
years much of periodontal research focused on identifying virulence factors of these three
bacteria in the context of a conventional infectious disease (Holt and Ebersole, 2005).
However, the dramatic differences in the composition of the microbiota in periodontal
disease versus health could alternatively be interpreted by a non-classical view of microbial
etiology of disease. According to this viewpoint, periodontal pathogens may not directly
cause periodontitis but rather reshape the normally symbiotic microbiota into a dysbiotic one
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that disrupts the normal homeostatic relationship with the host tissue. In this context, P.
gingivalis was suspected to be an orchestrator of periodontal disease by virtue of its
sophisticated strategies to subvert host immunity. Specifically, the capacity of P. gingivalis
to impair innate immunity could alter the growth and development of the entire periodontal
biofilm. The overgrowth of a dysbiotic biofilm, stabilized by the presence of P. gingivalis,
could in turn break down the host-microbial homeostasis in the periodontium and trigger
destructive inflammation. This hypothesis led to the studies showing that P. gingivalis can
act as a keystone member of the disease-provoking periodontal microbial community
(Hajishengallis, et al., 2011). The “keystone species” concept was originally proposed by the
ecologist R.T. Paine in 1969 (Paine, 1969). In the ecological literature, keystones are species
whose effects on their communities are inordinately large relative to their abundance. Such
species are thought to constitute the “keystone” of the community's structure in a way
reminiscent of a keystone in an arch (reviewed by (Hajishengallis et al., 2012).
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Consistent with the above discussed hypothesis, the colonization of the murine periodontium
by P. gingivalis was shown to be accompanied by significant alterations in the numbers and
community organization of the commensal bacteria, followed by inflammation and
destruction of the tooth-supporting bone (Hajishengallis, et al., 2011). Intriguingly, P.
gingivalis caused these dysbiotic alterations while present only at very low numbers,
specifically < 0.01% of the total bacterial counts. Moreover, P. gingivalis failed to cause
periodontitis by itself in germ-free mice despite its ability to colonize their periodontium
(Hajishengallis, et al., 2011). Therefore, the dysbiotic microbiota that develops in the
presence of P. gingivalis is most likely the eventual cause of the disease.

NIH-PA Author Manuscript

A major question addressed in the same study was whether complement was involved in P.
gingivalis-instigated dysbiosis. Since C5aR was shown earlier to be critical for the ability of
P. gingivalis to subvert leukocytes (Liang, et al., 2011; Wang, et al., 2010) (Figure 1), it was
hypothesized that C5aR-deficient mice would be resistant to P. gingivalis-induced dysbiosis.
Indeed, this bacterium failed to alter the commensal microbiota in the absence of C5aR.
Moreover, an isogenic mutant of P. gingivalis lacking gingipain activity failed to alter the
commensal microbiota in normal mice (Hajishengallis, et al., 2011). In both cases, the
failure to transform the normal commensal microbiota into a dysbiotic state prevented the
development of periodontal inflammation and bone loss. Therefore, mice are protected from
P. gingivalis-induced dysbiosis when the pathogen does not have access to C5aR or lacks
the enzyme to exploit this receptor. In contrast, under conditions that allow C5aR
exploitation by P. gingivalis (i.e., wild-type mice orally inoculated with the wild-type
organism), there is uncontrolled growth of commensal bacteria which leads to complementdependent inflammation that destroys the periodontal bone (Hajishengallis, et al., 2011).
Periodontal inflammation may also generate tissue breakdown products (e.g., degraded
proteins and hemin), which serve bacterial nutritional needs and can stabilize the transition
to a disease-provoking microbiota (Figure 2). In this regard, the inflammatory changes in the
periodontium can be better exploited by proteolytic and asaccharolytic bacteria, that is,
species associated with periodontal disease rather than health (Darveau, 2010). Those
bacteria that cannot utilize these nutrients, or for which host inflammation is detrimental, are
likely to be outcompeted or eliminated. As outlined above, complement is centrally involved
in this self-feeding vicious cycle of periodontal dysbiosis and destructive inflammation
(Figure 2).

Therapeutic implications in human periodontitis
Complement components can be found in active form in the gingival crevicular fluid at up to
70% of their concentration in serum, although certain components can be found at much
higher levels reflecting local production in the periodontium (Potempa, et al., 2009). Clinical
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and histological observations suggest that complement may be involved in the pathogenesis
of human periodontitis (Hajishengallis, 2010). Indeed, inflamed gingiva or samples of
crevicular fluid from periodontitis patients have increased levels of activated complement
fragments relative to control samples from healthy individuals (Beikler et al., 2008; Courts
et al., 1977; Niekrash and Patters, 1986; Nikolopoulou-Papaconstantinou et al., 1987; Patters
et al., 1989; Rautemaa and Meri, 1996; Schenkein and Genco, 1977). Moreover,
experimental induction of gingival inflammation in human volunteers causes progressive
elevation of complement cleavage products correlating with increased clinical indices of
inflammation (Patters, et al., 1989).
Although the data from the human studies are correlative, the findings that C5aR-deficient
mice are resistant to experimental periodontitis establish an intimate link between
complement and periodontal pathogenesis (Hajishengallis, et al., 2011; Liang, et al., 2011).
Importantly, treatment of P. gingivalis-colonized mice with a C5aR antagonist leads to the
elimination of P. gingivalis from the periodontium and reverses the dysbiotic changes that
are required for the development of periodontitis (Hajishengallis, et al., 2011). This
observation provides a causal link between complement and periodontitis and offers proofof-concept that dysbiotic diseases could be treated by specific targeting of keystone
pathogens. From a periodontal point of view, the same observation suggests that
complement therapeutics may find application in the treatment of human periodontitis.
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Conclusions
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The subversive action of P. gingivalis on complement may explain, at least in part, its ability
to persist in the periodontium and establish dysbiotic inflammation. P. gingivalis is perhaps
the first documented case of a keystone pathogen in microbial ecology as it fulfills the
criteria of low abundance and major influence on the microbial community, which is
remodeled in a way that promotes periodontal pathogenesis (Hajishengallis, et al., 2011).
Moreover, available evidence suggests that keystone pathogens may underlie the etiology of
also other polymicrobial inflammatory diseases (Hajishengallis et al., 2012). Although
established in the mouse model, the keystone pathogen concept is consistent with
observations in non-human primates and in humans (reviewed by Darveau et al., 2012).
Briefly, immunization of Macaca fascicularis with a gingipain-based vaccine resulted in
suppression of the counts of indigenous P. gingivalis accompanied by a reduction in the total
subgingival bacterial load and protection against bone loss (Page et al., 2007). Moreover, P.
gingivalis is a quantitatively minor component of human periodontitis-associated biofilms
(Doungudomdacha, et al., 2000; Kumar, et al., 2006; Moore, et al., 1982), despite its
association with progressive bone loss in periodontitis patients (Chaves, et al., 2000; Moore,
et al., 1991). Nevertheless, even at this low abundance, P. gingivalis exploits complement
and triggers dysbiotic changes that set the stage for inflammatory periodontitis. The ongoing
elucidation of the mechanisms underlying these interactions may facilitate the development
of novel therapeutic interventions in human periodontitis.
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Figure 1. Exploitation of signaling crosstalk by P. gingivalis
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P. gingivalis interacts with Toll-like receptor (TLR)-2 (as part of a CD14–TLR2–TLR1
signaling complex) and with TLR4. The activation of TLR4 is suppressed by the bacterium's
atypical lipopolysaccharide which acts as an antagonist. The TLR2 response is manipulated
through crosstalk with other innate receptors. By means of Arg-specific cysteine proteinases
that release biologically active C5a from C5, P. gingivalis activates the C5a receptor (C5aR)
and induces intracellular Ca2+ signaling which synergistically enhances the otherwise weak
cAMP responses induced by TLR2 activation alone. Maximal cAMP induction requires the
participation of CXC-chemokine receptor 4 (CXCR4), which is activated directly by the
bacterium's fimbriae. The resulting activation of the cAMP-dependent protein kinase A
(PKA) inactivates glycogen synthase kinase-3" (GSK3") and inhibits the inducible nitric
oxide synthase (iNOS)-dependent killing of the pathogen in macrophages. An additional
pathway induced downstream of TLR2 is an inside-out signaling pathway, mediated by
RAC1, phosphatidylinositol-3 kinase (PI3K) and cytohesin 1 (CYT1), which transactivates
complement receptor-3 (CR3). Activated CR3 binds P. gingivalis and induces extracellular
signal-regulated kinase-1/ERK2 signaling, which in turn selectively downregulates IL-12
p35 and p40 mRNA expression through suppression of interferon regulatory factor 1 (IRF1).
Inhibition of bioactive IL-12, and secondarily IFN#, leads to impaired immune clearance of
P. gingivalis.
From Hajishengallis and Lambris, 2011, Nature Reviews Immunology, 11, 187–200 (used
by permission).
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Figure 2. P. gingivalis exploits complement and causes dysbiotic inflammation
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P. gingivalis subverts complement and impairs host defense leading to altered composition
and increased numbers of periodontal commensal bacteria which, in turn, cause
complement-dependent periodontal inflammation and bone loss. The inflammatory
environment is favorable to further bacterial growth as it provides the dysbiotic microbiota
with a nutrient-rich gingival inflammatory exudate. Numbers indicate a possible sequence of
events, although the overall process represents a self-feeding cycle that drives and sustains
persistent inflammation.
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Subversion of complement and TLRs by P. gingivalis
Mechanism

Effector molecules

Refs.

1

Inhibition of complement activation by degrading the
central complement component (C3)

Gingipains, especially HRgpA &
RgpB

(Popadiak, et al., 2007; Potempa, et al.,
2009)

2

Hijacking negative regulators of complement (C4bbinding protein)

HRgpA

(Potempa, et al., 2008)

3

Proactive generation of C5a for instigating subversive
C5aR-TLR2 crosstalk

HRgpA & RgpB

(Liang, et al., 2011; Wang, et al., 2010)

4

Transactivation of CR3 and exploitation of CR3mediated phagocytosis

Fimbriae

(Liang, et al., 2011; Wang, et al., 2007)

5

Suppression of TLR2-induced IL-12 via CR3 binding
or C5aR activation

Fimbriae or HRgpA & RgpB

(Hajishengallis, et al., 2007; Liang, et
al., 2011)

6

TLR4 evasion by expressing dephosphorylated tetraacylated lipid A

Lipid A 1- and 4-phosphatases &
deacylase

(Coats, et al., 2009)

7

TLR4 antagonism by expressing monophosphorylated
tetra-acylated lipid A

Lipid A 4-phosphatase & deacylase
(lipid A 1-phosphatase suppressed
by hemin)

(Coats, et al., 2005; Coats, et al., 2009)
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